Truong, Matthew <br/><br/>
Using the epigenetic field defect to detect prostate cancer in biopsy negative patients.  [electronic resource] 

 -  The Journal of urology  Jun 2013 
 - 2335-41 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1527-3792 
<br/><br/><label>Standard No.: </label>10.1016/j.juro.2012.11.074  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Biopsy, Needle<br/>DNA Methylation<br/>Epigenomics--methods<br/>Fibroblast Growth Factor 1--genetics<br/>Gene Expression Regulation, Neoplastic<br/>Genetic Markers<br/>Homeodomain Proteins--genetics<br/>Humans<br/>Immunohistochemistry<br/>Male<br/>Middle Aged<br/>Predictive Value of Tests<br/>Prostatic Neoplasms--genetics<br/>Reference Values<br/>Regression Analysis<br/>Reproducibility of Results<br/>Risk Factors<br/>Sensitivity and Specificity<br/>Statistics, Nonparametric<br/>Tissue Culture Techniques